Theresa L. Whiteside

University of Pittsburgh

NIH Rank #3973
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.4M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#3,973
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.4M across 5 grants · National rank #3973.

Top grants by award amount

Theresa L. Whiteside's NIH grant portfolio, ranked by award amount.

  • 5U01DE029759-05U01
    Depleting exosomes to improve responses to immune therapy in HNSCC
    $699.2K
    award amount
  • 5R01DE031299-02R01
    Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
    $686K
    award amount
  • 5R01CA256068-04R01
    The Adenosinergic Pathway in Tumor-derived Exosomes
    $477.7K
    award amount
  • 5P50CA254865-04P50
    Melanoma and Skin Cancer Program SPORE
    $381.6K
    award amount
  • 3R01DE031299-02S1R01
    Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
    $131K
    award amount

Affiliation

Institutions that have administered grants for Theresa L. Whiteside.

Affiliated with University of Pittsburgh (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3973
  6. 2024
    Entered Top 25% Nationally
    Ranked #3973